[{"address1": "770 Lindaro Street", "city": "San Rafael", "state": "CA", "zip": "94901", "country": "United States", "phone": "415 506 6700", "website": "https://www.biomarin.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "BioMarin Pharmaceutical Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria (PKU), an inherited metabolic disease. The company's commercial products also comprise Palynziq, a PEGylated recombinant phenylalanine ammonia lyase enzyme, which is delivered through subcutaneous injection to reduce blood Phe concentrations; Brineura, a recombinant human tripeptidyl peptidase 1 for the treatment of patients with ceroid lipofuscinosis type 2, a form of Batten disease; Voxzogo, a once daily injection analog of c-type natriuretic peptide for the treatment of achondroplasia; and Aldurazyme, a purified protein designed to be identical to a naturally occurring form of the human enzyme alpha-L-iduronidase. In addition, it develops Roctavian, an adeno associated virus vector, for the treatment of patients with severe hemophilia A. The company serves specialty pharmacies, hospitals, and non-U.S. government agencies, as well as distributors and pharmaceutical wholesalers in the United States, Europe, Latin America, and internationally. It has license and collaboration agreements with Sarepta Therapeutics; Ares Trading S.A.; Catalyst Pharmaceutical Partners, Inc.; and CAMP4 Therapeutics Corporation. The company was incorporated in 1996 and is headquartered in San Rafael, California.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Alexander  Hardy", "age": 55, "title": "President, CEO & Director", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 1715598, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian R. Mueller CPA", "age": 50, "title": "CFO & Executive VP", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 1074819, "exercisedValue": 2474925, "unexercisedValue": 1185108}, {"maxAge": 1, "name": "Dr. C. Greg Guyer Ph.D.", "age": 62, "title": "Executive VP & CTO", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 1114215, "exercisedValue": 0, "unexercisedValue": 876749}, {"maxAge": 1, "name": "Dr. Henry J. Fuchs M.D., Ph.D.", "age": 66, "title": "Advisor", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 1411725, "exercisedValue": 0, "unexercisedValue": 3725258}, {"maxAge": 1, "name": "Ms. Erin  Burkhart", "age": 45, "title": "Group VP & Chief Accounting Officer", "yearBorn": 1979, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kevin  Eggan Ph.D.", "title": "Chief Scientific Officer & Senior VP of Research and Early Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Traci  McCarty", "title": "Group Vice President of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. George Eric Davis J.D.", "age": 53, "title": "Executive VP, Chief Legal Officer, General Counsel & Secretary", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 1231702, "exercisedValue": 2113615, "unexercisedValue": 4885664}, {"maxAge": 1, "name": "Ms. Amy  Wireman", "title": "Executive VP & Chief People Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ganesh  Vedantham Ph.D.", "title": "Senior Vice President of Technical Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 2, "boardRisk": 2, "compensationRisk": 5, "shareHolderRightsRisk": 5, "overallRisk": 3, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "irWebsite": "http://investors.bmrn.com/index.cfm", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 68.73, "open": 68.77, "dayLow": 67.76, "dayHigh": 70.26, "regularMarketPreviousClose": 68.73, "regularMarketOpen": 68.77, "regularMarketDayLow": 67.76, "regularMarketDayHigh": 70.26, "payoutRatio": 0.0, "beta": 0.283, "trailingPE": 30.882353, "forwardPE": 22.826086, "volume": 2230599, "regularMarketVolume": 2230599, "averageVolume": 1524110, "averageVolume10days": 1471490, "averageDailyVolume10Day": 1471490, "bid": 64.84, "ask": 68.36, "bidSize": 1, "askSize": 7, "marketCap": 13019438080, "fiftyTwoWeekLow": 60.63, "fiftyTwoWeekHigh": 94.85, "priceToSalesTrailing12Months": 4.5619574, "fiftyDayAverage": 64.9374, "twoHundredDayAverage": 74.50955, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 12568459264, "profitMargins": 0.14957, "floatShares": 178581237, "sharesOutstanding": 190760992, "sharesShort": 4504362, "sharesShortPriorMonth": 4542138, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.023599999, "heldPercentInsiders": 0.00947, "heldPercentInstitutions": 0.98491997, "shortRatio": 2.67, "shortPercentOfFloat": 0.0238, "impliedSharesOutstanding": 190760992, "bookValue": 29.66, "priceToBook": 2.3010788, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "earningsQuarterlyGrowth": 5.132, "netIncomeToCommon": 426859008, "trailingEps": 2.21, "forwardEps": 2.99, "enterpriseToRevenue": 4.404, "enterpriseToEbitda": 18.853, "52WeekChange": -0.24671197, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 68.25, "targetHighPrice": 126.0, "targetLowPrice": 65.0, "targetMeanPrice": 96.71222, "targetMedianPrice": 94.0, "recommendationMean": 1.72414, "recommendationKey": "buy", "numberOfAnalystOpinions": 27, "totalCash": 1137705984, "totalCashPerShare": 5.964, "ebitda": 666640000, "totalDebt": 595137984, "quickRatio": 2.963, "currentRatio": 5.325, "totalRevenue": 2853914880, "debtToEquity": 10.519, "revenuePerShare": 15.018, "returnOnAssets": 0.05154, "returnOnEquity": 0.080469996, "grossProfits": 1526496000, "freeCashflow": 279652512, "operatingCashflow": 572841024, "earningsGrowth": 6.393, "revenueGrowth": 0.156, "grossMargins": 0.53488, "ebitdaMargins": 0.23358999, "operatingMargins": 0.2481, "financialCurrency": "USD", "symbol": "BMRN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NMS", "messageBoardId": "finmb_25605", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "regularMarketChangePercent": -0.6983899, "regularMarketPrice": 68.25, "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "BioMarin Pharmaceutical Inc.", "longName": "BioMarin Pharmaceutical Inc.", "corporateActions": [], "postMarketTime": 1740171922, "regularMarketTime": 1740171601, "marketState": "POST", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 932995800000, "postMarketChangePercent": -0.8058653, "postMarketPrice": 67.7, "postMarketChange": -0.55000305, "regularMarketChange": -0.48000336, "regularMarketDayRange": "67.76 - 70.26", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1524110, "fiftyTwoWeekLowChange": 7.619999, "fiftyTwoWeekLowChangePercent": 0.12568034, "fiftyTwoWeekRange": "60.63 - 94.85", "fiftyTwoWeekHighChange": -26.599998, "fiftyTwoWeekHighChangePercent": -0.2804428, "fiftyTwoWeekChangePercent": -24.671196, "earningsTimestamp": 1739999105, "earningsTimestampStart": 1745319540, "earningsTimestampEnd": 1745841600, "earningsCallTimestampStart": 1740000600, "earningsCallTimestampEnd": 1740000600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 2.21, "epsForward": 2.99, "epsCurrentYear": 4.27318, "priceEpsCurrentYear": 15.971712, "fiftyDayAverageChange": 3.3125992, "fiftyDayAverageChangePercent": 0.051012192, "twoHundredDayAverageChange": -6.259552, "twoHundredDayAverageChangePercent": -0.084010065, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.7 - Buy", "cryptoTradeable": false, "displayName": "BioMarin Pharmaceutical", "trailingPegRatio": 0.4301, "__fetch_time": "2025-02-21"}]